Epstein-Barr virus: exploiting the immune system
Top Cited Papers
- 1 October 2001
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 1 (1) , 75-82
- https://doi.org/10.1038/35095584
Abstract
In vitro, Epstein-Barr virus (EBV) will infect any resting B cell, driving it out of the resting state to become an activated proliferating lymphoblast. Paradoxically, EBV persists in vivo in a quiescent state in resting memory B cells that circulate in the peripheral blood. How does the virus get there, and with such specificity for the memory compartment? An explanation comes from the idea that two genes encoded by the virus — LMP1 and LMP2A — allow EBV to exploit the normal pathways of B-cell differentiation so that the EBV-infected B blast can become a resting memory cell.Keywords
This publication has 95 references indexed in Scilit:
- Notch1IC Partially Replaces EBNA2 Function in B Cells Immortalized by Epstein-Barr VirusJournal of Virology, 2001
- Localization of the Major NF-κB-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling MotifsJournal of Biological Chemistry, 1997
- Germinal center developmentImmunological Reviews, 1997
- Identification of TRAF6, a Novel Tumor Necrosis Factor Receptor-associated Factor Protein That Mediates Signaling from an Amino-terminal Domain of the CD40 Cytoplasmic RegionPublished by Elsevier ,1996
- Germinal CentersAnnual Review of Immunology, 1994
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985
- Epstein-Barr virus susceptibility of normal human B lymphocyte populations.The Journal of Experimental Medicine, 1984
- X-Linked Lymphoproliferative Syndrome Registry reportThe Journal of Pediatrics, 1980
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964